Drugs & Medical Devices

Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.



Issue #82, October 2008

State High Court to Hear Appeal of Vioxx Preemption Ruling

The New Jersey Supreme Court has agreed to hear the appeal of a nearly $4.5 million Vioxx verdict and whether jurors properly considered the preemptive

N.J. Zelnorm Cases Centralized, But Without 'Mass Tort' Designation

The New Jersey Supreme Court has transferred all pending Zelnorm injury cases to a single judge, but took the unusual step of

Federal Judge Grants Adventis Summary Judgment in Insulin Case

A Puerto Rico federal judge granted Adventis Pharma summary judgment in a Lantus wrongful death lawsuit, ruling that

MDL Court Retains W. Va. Attorney General's Suit Against Lilly

A New York federal judge has refused to remand a Zyprexa lawsuit brought by the West Virginia attorney general against Eli Lilly & Co.

Federal Judge Sends Paxil Teen Suicide Case to Trial

A federal judge has denied GlaxoSmithKline summary judgment in a Paxil lawsuit, ruling that issues of material fact exist as to

Court: Vaccine Makers Not Immune from Thimerosal Design Defect Claim

A state Supreme Court has allowed design defect claims to proceed against the manufacturer of a vaccine that allegedly caused

Texas Judge Cites Lilly Profits in Rejecting Company's Zyprexa Fee Request

Noting that Eli Lilly & Co. made nearly $3 billion in 2007, a federal judge has refused to award the company attorney fees

Judge Says State Law Protopic Claims Don't Confer Federal Jurisdiction

Allegations that a prescription skin cream caused a man's fatal non-Hodgkin's lymphoma do not involve federal questions sufficient to

Suit Against Generic Drug Maker is Not Preempted, Calif. Panel Rules

State-law failure-to-warn claims brought against a generic drug manufacturer in a metoclopramide-related action are not preempted by federal law

Issue #81, September 2008

Court Reverses Application of Collateral Estoppel to Paxil Class Action Claim

Class allegations that GlaxoSmithKline deceived residents by falsely advertising that the drug was non-habit-forming may proceed

Past Issues:


The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.